BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9683826)

  • 1. Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
    Tsavaris N; Mylonakis N; Bacoyiannis C; Kosmas C; Kalergis G; Iakovidis V; Tzaninis D; Kosmidis P
    Oncol Rep; 1998; 5(5):1147-55. PubMed ID: 9683826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
    Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P
    Anticancer Res; 2000; 20(6C):4777-83. PubMed ID: 11205218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy.
    Tsavaris NB; Koufos C; Katsikas M; Dimitrakopoulos A; Athanasiou E; Linardaki G
    J Pain Symptom Manage; 1999 Sep; 18(3):218-22. PubMed ID: 10517044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four antiemetic regimens for the treatment of cisplatin-induced vomiting.
    Póka R; Hernádi Z; Juhász B; Lampé L
    Int J Gynaecol Obstet; 1993 Jul; 42(1):19-24. PubMed ID: 8103470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antiemetics for cisplatin chemotherapy.
    Sridhar KS; Donnelly E
    Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report.
    Mantovani G; Curreli L; Macciò A; Massa E; Massa D; Mulas C; Succu G; Contu P
    Anticancer Res; 1999; 19(4C):3495-502. PubMed ID: 10629642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
    Cognetti F; Pinnarò P; Carlini P; Conti EM; Cortese M; Pollera CF
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):183-7. PubMed ID: 6368241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
    Tsavaris NB; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
    Acta Oncol; 1990; 29(8):1005-9. PubMed ID: 2278720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Roila F; Basurto C; Bracarda S; Picciafuoco M; Ballatori E; Del Favero A; Tonato M
    Oncology; 1990; 47(5):415-7. PubMed ID: 2216296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
    Plezia PM; Alberts DS; Kessler J; Aapro MS; Graham V; Surwit EA
    Cancer Treat Rep; 1984 Dec; 68(12):1493-5. PubMed ID: 6542448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
    Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized crossover antiemetic study in cisplatin-treated patients. Comparison between high-dose i.v. metoclopramide and high-dose i.v. dexamethasone.
    Frustaci S; Grattoni E; Tumolo S; Crivellari D; Figoli F; Galligioni E; Veronesi A; Tirelli U; Grigoletto E
    Cancer Chemother Pharmacol; 1986; 17(1):75-9. PubMed ID: 3698180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients.
    Sorbe B; Hallén C
    Eur J Gynaecol Oncol; 1991; 12(1):31-7. PubMed ID: 2050157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
    Dozono H; Yasuda M; Yokoyama S; Takahashi S; Ochiai K; Tsuruoka M; Morimoto O; Sasaki H; Arihiro T; Terashima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1968-72. PubMed ID: 3429979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.